Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rupert Bauersachs"'
Rivaroxaban Versus Fondaparinux in the Treatment of Superficial Vein Thrombosis - the Surprise Trial
Autor:
Sebastian Schellong, Jan Beyer-Westendorf, Horst E. Gerlach, Eberhard Rabe, Rupert Bauersachs, Katja Jersemann, Kurtulus Sahin
Publikováno v:
Blood. 128:85-85
Background The current standard of therapy in superficial vein thrombosis (SVT) comprises subcutaneous injections of the indirect factorXainhibitorfondaparinuxfor up to 45 days, which was highlyeffectivecompared to placebo in the CALISTO trial. Howev
Autor:
Mikala F. Jarner, Mette S. Janas, Alok A. Khorana, Pieter Willem Kamphuisen, Rupert Bauersachs, Agnes Y.Y. Lee, Guy Meyer
Publikováno v:
Blood. 124:LBA-2
Background Patients with cancer and VTE have a substantial risk of recurrent VTE. LMWH reduces the risk of symptomatic, recurrent VTE compared with warfarin and is recommended as the preferred anticoagulant by consensus guidelines. However, the evide
Autor:
Rupert Bauersachs, Dialina Brilhante, G T Gerotzafias, Mario Mandalà, Simon Noble, Henri Bounameaux, Ramón Lecumberri, Anna Falanga, H. R. Büller, Michael B. Streiff, C. Baglin, Nissim Haim, Manuel Monreal, Alok A. Khorana, Michel Marty, Dominique Farge, Mohammed H. Qari, Shaker A. Mousa, Philippe Debourdeau, M Beckers, Ingrid Pabinger, Barry M. Brenner, Paolo Prandoni, Ajay K. Kakkar, Martin H. Prins, Konstantinos N. Syrigos
Publikováno v:
Journal of Thrombosis and Haemostasis, 11(1), 71-80. Wiley
Journal of thrombosis and haemostasis, 11(1), 71-80. Wiley-Blackwell
Journal of Thrombosis and Haemostasis, Vol. 11, No 1 (2013) pp. 71-80
Journal of thrombosis and haemostasis, 11(1), 71-80. Wiley-Blackwell
Journal of Thrombosis and Haemostasis, Vol. 11, No 1 (2013) pp. 71-80
Abstract 4357 Background Use of long term indwelling central venous catheter (CVC) is associated with symptomatic (Σ) events in up to 30% of cancer patients (pts), which may lead to pulmonary embolism (PE) and loss of the CVC. Lack of consensus on m
Autor:
Debourdeau Philippe, Nissim Haim, Shaker S Mousa, Michel Marthy, C. Baglin, Beckers Marielle, Konstantin Syrigos, Martin H. Prins, Harry R. Büller, Mohammed H. Qari, Mario Mandalà, Ajay K. Kakkar, Manuel Monreal, Paolo Prandoni, Benjamin Brenner, Grigoris T. Gerotziafas, Ingrid Pabinger, Farge Dominique, Simon Noble, Michael B. Streiff, Anna Falanga, Alok A. Khorana, Ramón Lecumberri, Henri Bounameaux, Dialina Brilhante, Rupert Bauersachs
Publikováno v:
Blood. 120:1161-1161
Abstract 1161 Background Heterogeneity in clinical practices worldwide for Venous Thromboembolism (VTE) is a major challengs. This concern led us to establish international good clinical practices guidelines (GCPG) for the management VTE in cancer pa